The Latest Breaking News from Amgen

The Dow Jones Industrial Average reversed lower Friday, as Federal Reserve Chairman Jerome Powell warned of "some pain" to fight inflation.

Amgen is showing very low implied volatility compared to recent history. That could mean it’s a good time to buy an option strangle.

The biotech industry is expected to see solid growth in the long term due to rising healthcare spending, breakthrough developments, and an aging population. Given the industry’s solid growth prospects and non-cyclical nature, it could be wise to invest in fundamentally strong biotech stocks Gilead Sciences (GILD), Biogen (BIIB), Jazz…

  A whale with a lot of money to spend has taken a noticeably bullish stance on Amgen. Looking at options history for Amgen (NASDAQ:AMGN) we detected 10 strange trades.

The stock market traded mixed on Friday on hot job numbers, closing out the week with gains. AMC popped on earnings beat.

The stock market rally had mixed action, with the Nasdaq and small caps rising while the S&P 500 and oil prices fell.

The Dow Jones Industrial Average dropped Friday on a strong jobs report. And shareholders approved plans for a 3-for-1 Tesla stock split.

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.

U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.